APONTIS PHARMA AG (APPH.DE) Stock Price, Forecast & Analysis
Europe - Frankfurt Stock Exchange - FRA:APPH - DE000A3CMGM5 - Common Stock
APPH.DE Key Statistics, Chart & Performance
The current stock price of APPH.DE is 11 EUR. In the past month the price increased by 1.85%. In the past year, price increased by 13.17%.
APPH.DE Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| SNW.DE | SANOFI | 11.11 | 205.06B | ||
| SAN.PA | SANOFI | 11.11 | 205.10B | ||
| 1SAN.MI | SANOFI | 10.89 | 201.12B | ||
| MRK.DE | MERCK KGAA | 15.04 | 55.78B | ||
| UCB.BR | UCB SA | 39.69 | 49.56B | ||
| UNC.DE | UCB SA | 39.33 | 49.11B | ||
| BAYN.DE | BAYER AG-REG | 7.28 | 38.20B | ||
| 1BAYN.MI | BAYER AG-REG | 7.28 | 38.20B | ||
| IPN.PA | IPSEN | 12.41 | 10.68B | ||
| REC.MI | RECORDATI INDUSTRIA CHIMICA | 25.17 | 10.37B | ||
| TUB.BR | FINANCIERE DE TUBIZE | 108.17 | 10.01B | ||
| 1JAZZ.MI | JAZZ PHARMACEUTICALS PLC | 21.05 | 8.94B |
Related stock screener links
About APPH.DE
Company Profile
APONTIS PHARMA AG engages in the development, promotion, and sale of single pills and other pharmaceutical products. The company is headquartered in Monheim Am Rhein, Nordrhein-Westfalen and currently employs 137 full-time employees. The company went IPO on 2021-05-11. The firm focuses on the commercialization of pharmaceutical products to General Practitioners and engages in the marketing and sale of medical drugs for indication fields of internal medicine in Germany.
Company Info
APONTIS PHARMA AG
Rolf-Schwarz-Schuette-Platz 1
Monheim Am Rhein NORDRHEIN-WESTFALEN DE
Employees: 137
APONTIS PHARMA AG / APPH.DE FAQ
Can you describe the business of APONTIS PHARMA AG?
APONTIS PHARMA AG engages in the development, promotion, and sale of single pills and other pharmaceutical products. The company is headquartered in Monheim Am Rhein, Nordrhein-Westfalen and currently employs 137 full-time employees. The company went IPO on 2021-05-11. The firm focuses on the commercialization of pharmaceutical products to General Practitioners and engages in the marketing and sale of medical drugs for indication fields of internal medicine in Germany.
Can you provide the latest stock price for APONTIS PHARMA AG?
The current stock price of APPH.DE is 11 EUR.
Does APPH stock pay dividends?
APPH.DE does not pay a dividend.
How is the ChartMill rating for APONTIS PHARMA AG?
APPH.DE has a ChartMill Technical rating of 6 out of 10 and a ChartMill Fundamental rating of 5 out of 10.
Which stock exchange lists APPH stock?
APPH.DE stock is listed on the Frankfurt Stock Exchange exchange.
What is the Price/Earnings (PE) ratio of APONTIS PHARMA AG (APPH.DE)?
The PE ratio for APONTIS PHARMA AG (APPH.DE) is 122.22. This is based on the reported non-GAAP earnings per share of 0.09 and the current share price of 11 EUR.
What is the market capitalization of APPH stock?
APONTIS PHARMA AG (APPH.DE) has a market capitalization of 93.50M EUR. This makes APPH.DE a Micro Cap stock.
APPH.DE Technical Analysis
ChartMill assigns a technical rating of 6 / 10 to APPH.DE. When comparing the yearly performance of all stocks, APPH.DE is one of the better performing stocks in the market, outperforming 71.59% of all stocks.
APPH.DE Fundamental Analysis
ChartMill assigns a fundamental rating of 5 / 10 to APPH.DE. APPH.DE has a great financial health rating, but its profitability evaluates not so good.
APPH.DE Financial Highlights
Over the last trailing twelve months APPH.DE reported a non-GAAP Earnings per Share(EPS) of 0.09. The EPS increased by 106.98% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 1.55% | ||
| ROA | 1.7% | ||
| ROE | 2.34% | ||
| Debt/Equity | 0 |
APPH.DE Forecast & Estimates
7 analysts have analysed APPH.DE and the average price target is 13.77 EUR. This implies a price increase of 25.18% is expected in the next year compared to the current price of 11.
For the next year, analysts expect an EPS growth of 393.69% and a revenue growth 21.53% for APPH.DE